Criteria associated with the distribution of series lists might differ between submitting in the United States and submitting globally

  • (D) sentences 4(v) and 4bis(iv) of WIPO criterion ST.25 (2009) requires the specific wording « the details recorded in digital type supplied under PCT tip 13ter is actually identical to the series listing »; and
  • (E) WIPO criterion ST.25 (2009), paragraph 24, needs an empty line between numeric identifiers in the sequence list as soon as the digit in the 1st or 2nd position in the numeric identifier changes.

Including, where a worldwide program was submitted in paper, the series listing part of the international software additionally needs to become supplied in paper, although the search backup needs to be registered in electronic form, e.g. on a CD or, for the RO/US, as an ASCII text document via EFS-Web. Furthermore, any dining tables submitted in a worldwide application must certanly be a fundamental piece of the program, in other words., shouldn’t be presented as another file in book format.

37 CFR 1.821(a) provides a definition for « nucleotide and/or amino acid sequences. » This classification sets forth limitations, in terms of variety of amino acids and/or quantities of nucleotides, at or above which conformity utilizing the series formula is needed. Nucleotide and/or amino acid sequences as found in 37 CFR 1.821 through 37 CFR 1.825 include interpreted to imply an unbranched sequence of four or higher proteins or an unbranched sequence of ten or even more nucleotides. Branched sequences include particularly excluded with this description. Sequences with less than ten particularly identified nucleotides or four specifically identified amino acids tend to be especially omitted out of this area. « Especially explained » indicates those proteins other than « Xaa » and the ones nucleotide bases except that « n » identified in accordance with the Business Intellect Homes Organization (WIPO) Handbook on Industrial Home Suggestions and Records, Traditional ST.25: Requirement your Presentation of Nucleotide and Amino Acid Sequence Directories in Patent Applications (1998), like Tables 1 through 6 in Appendix 2 (see MPEP A§ 2422).

The limitation of four or more proteins was demonstrated for consistency with limits in place for field databases choices whereas the limitation of ten or even more nucleotides, while lower than particular field database limitations, was established to cover those nucleotide sequences to which the tiniest probe will bind in a reliable fashion.

Voluntary conformity are, but inspired within these situations; the signal « Xaa » can help portray D-amino acids

37 CFR 1.821(a)(1) and 37 CFR 1.821(a)(2) found additional descriptions for those of you nucleotide and amino acid sequences which are supposed to be embraced by sequence principles. Situations when the usefulness from the formula is during problem would be settled on a case-by-case grounds.

The Office will not like to omit linkages associated with the sort generally present in naturally occurring nucleotides, e

Nucleotide sequences tend to be further restricted to those that tends to be represented by symbols established in 37 CFR 1.822(b), which incorporates by resource WIPO Standard ST.25 (1998), Appendix 2, Table 1 (see fruzo VyhledГЎvГЎnГ­ MPEP A§ 2422). The existence of except that common 5′ to 3′ phosphodiester linkages in a nucleotide series doesn’t make the rules inapplicable. g., eukaryotic end capped sequences.

Amino acid sequences is further limited by those placed in 37 CFR 1.822(b), which includes by reference WIPO common ST.25 (1998), Appendix 2, desk 3 (see MPEP A§ 2422), and people L-amino acids which can be commonly present natural proteins. The existence of several D-amino acids in a sequence will exclude that series from the scope of this regulations. The series formula embrace « [a]ny peptide or proteins that may be shown as a sequence making use of the symbols in WIPO standards ST.25 (1998), Appendix 2, Table 3 in conjunction with a description for the Feature part to describe, as an example, altered linkages, combination links and end hats, non-peptidyl securities, etc. » 37 CFR 1.821(a)(2).

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée Champs requis marqués avec *

Publier des commentaires